Orphanet: Ricerca semplice
x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

200 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

CANADA

Ontario
TORONTO

FRANCIA

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Sperimentazione in fase di reclutamento
Sperimentazione in corso
NOVASED: Efficiency Clinical Study of NOVATEX MEDICAL Compression Garments in Patients With Ehlers-Danlos Syndrome.
CHU de Nancy - Hôpitaux de Brabois
Service de médecine interne et immunologie clinique

GERMANIA

Baden-Württemberg
FREIBURG

Sperimentazione in fase di reclutamento
Sperimentazione in corso
ABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

ITALIA

LOMBARDIA
PAVIA

REGNO UNITO; GRAN BRETAGNA

Humberside
COTTINGHAM

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Azithromycin a Treatment for Pulmonary Sarcoidosis (CAPS)
Hull York Medical School
Respiratory Medicine Clinical Trials Unit

REGNO UNITO; GRAN BRETAGNA

Norfolk
NORWICH

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in corso
Finanziato da un ente associato a IRDiRCMSC-LES: Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCIA

NOUVELLE AQUITAINE
LIMOGES

Sperimentazione in corso
AmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

GERMANIA

Baden-Württemberg
HEIDELBERG

Sperimentazione in corso
An open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

ITALIA

TOSCANA
FIRENZE

PORTOGALLO

NORTE
PORTO

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis (Phase I)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTOGALLO

NORTE
PORTO

Sperimentazione in corso
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTOGALLO

SUL
LISBOA

Sperimentazione in corso
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
Serviço de Neurologia

REGNO UNITO; GRAN BRETAGNA

Avon
BATH

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Sperimentazione in corso
A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

GERMANIA

Baden-Württemberg
TÜBINGEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANIA

Bayern
ERLANGEN

Sperimentazione in corso
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

GERMANIA

Berlin
BERLIN

Sperimentazione in corso
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

REGNO UNITO; GRAN BRETAGNA

Derbyshire
CHESTERFIELD

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Finanziato da un ente associato a IRDiRCPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Sperimentazione in corso
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNGHERIA

Közép-Magyarország
BUDAPEST

Sperimentazioni cliniche internazionali

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US